Viewing Study NCT03813394

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2026-02-02 @ 5:04 PM
Study NCT ID: NCT03813394
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-11-22
First Post: 2019-01-20
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bevacizumab and Pembrolizumab Combination in Platinum-resistant Recurrent/Metastatic NPC
Sponsor: National University Hospital, Singapore
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Locally Recurrent Cancer View
None Metastatic Nasopharyngeal Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Immunotherapy View
None Epstein Barr virus View
None Nasopharyngeal cancer View
None Anti-PD1 View
None Tumor neoantigens View